ÂÜÀòÂÒÂ×

Bob Ozelie has a strong background in finance and has held various leadership roles in different companies, including Cardinal Health, TIDI Products, LLC, and Genpact. Bob currently serves as the Chief Financial Officer at Kreg Therapeutics. Ozelie has expertise in areas such as FP&A, data management, pricing, and commercial strategy, and has shown proficiency in leading finance organizations and creating processes to support business initiatives. Bob holds a Bachelor's degree in Finance from Indiana University - Kelley School of Business.